Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411
Fig 2
Western blot detection of NCL.
(A) Western blot of extracts from different cell lines were first probed with anti-NCL antibody and afterwards reprobed with anti-GAPDH antibody for equal loading control. (B) Quantification of NCL expression relative to the expression of GAPDH and normalized to the mean value of the normal epithelial breast cell lines MCF-10A and 184A1.